Eramol Advances New UK Sterile Fill-Finish Facility for Early-Phase Injectable Manufacturing
Eramol is progressing the development of its purpose-built sterile fill-finish facility in Sevenoaks, Kent, designed to support Phase I and Phase II injectable clinical-trial programmes with flexible batch sizes, isolator-based aseptic processing with <0.1% line losses and integrated packaging, labelling, QC & UK and EU QP release.
Sevenoaks, UK: Eramol is advancing the development of its new sterile fill-finish facility in Sevenoaks, strengthening UK capacity for early-phase injectable clinical-trial manufacturing.